HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION

被引：0
|
作者：
MARIT, G
CONY, P
DAVID, B
BROUSTET, A
REIFFERS, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 1988年 / 3卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [21] High-dose idarubicin, busulphan and melphalan conditioning regimen for autograft in multiple myeloma
    Capria, S
    Petrucci, MT
    Ferrazza, G
    Ribersani, M
    Torromeo, C
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
  • [22] HIGH-DOSE MELPHALAN IS A SAFE CONDITIONING REGIMEN IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Cangini, D.
    Cerchione, C.
    Giannini, M. B.
    Di Battista, V.
    Frabetti, F.
    Petracci, E.
    Ronconi, S.
    Martinelli, G.
    HAEMATOLOGICA, 2019, 104 : 163 - 163
  • [23] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    M Cavo
    G Bandini
    M Benni
    A Gozzetti
    S Ronconi
    G Rosti
    E Zamagni
    RM Lemoli
    A Bonini
    A Belardinelli
    MR Motta
    S Rizzi
    S Tura
    Bone Marrow Transplantation, 1998, 22 : 27 - 32
  • [24] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    Cavo, M
    Bandini, G
    Benni, M
    Gozzetti, A
    Ronconi, S
    Rosti, G
    Zamagni, E
    Lemoli, RM
    Bonini, A
    Belardinelli, A
    Motta, MR
    Rizzi, S
    Tura, S
    BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 27 - 32
  • [25] High-Dose Melphalan Versus Busulfan, Cyclophosphamide As Conditioning Regimens for Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
    Styler, Michael
    Crilley, Pamela Ann
    Jain, Maneesh
    Ward, Kristine
    Topolsky, David
    Cho, David
    Kim, Marc
    BLOOD, 2015, 126 (23)
  • [26] CYCLOPHOSPHAMIDE, MELPHALAN AND TBI AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION FOR HIGH-RISK PATIENTS
    MARIT, G
    BOIRON, JM
    DAVID, B
    RICHAUD, P
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 315 - 315
  • [27] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jae-Cheol Jo
    Jin-Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Seong Nam Im
    Sang-Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Seong Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Annals of Hematology, 2021, 100 : 189 - 196
  • [28] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Seong Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 189 - 196
  • [29] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [30] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
12345